Lockstep collaboration, tailored experience

TriLink is not just a CDMO, but a collaborative manufacturing partner, guiding clients from preclinical development through early-phase clinical trials and into late-phase and commercial drug substance manufacturing. With deep mRNA expertise and purpose-built late-phase facilities, we ensure a smooth transition and robust support at every stage of your program.

• mRNA process, analytical, and regulatory expertise
• Phase-appropriate clinical development continuum from DOE to process validation
• Purpose-built, late-phase mRNA facilities
• Comprehensive PPQ roadmap